Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
10 Aug, 2026, 11.10 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
06 Aug, 2026, 01.04 PM IST
Been bitten by a dog and left with a wound? Doctor says one activity can increase risk of being diagnosed with rabies: ‘It introduces rabies virus to your nervous system…’Suffering a dog bite can be extremely painful. There is also the risk of becoming diagnosed with rabies, a fatal disease. However, there is...
02 Aug, 2026, 01.06 PM IST
Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
27 Jul, 2026, 12.52 PM IST
Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...
21 Jul, 2026, 02.58 PM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOil is crucial for every part of the Indian economy: From government to consumer, its price impacts spending by every stakeholder. So, till...
20 Jul, 2026, 06.05 PM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...
10 Jul, 2026, 12.20 PM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%As the market makes an attempt to move upward, there is a clear preference for sectors that are focused on the domestic market. Given this,...
06 Jul, 2026, 07.15 PM IST
Shigella outbreak in Kerala: 10 new cases reported taking tally to 226; here's everything you need to know about the infectionKerala is grappling with a surge in Shigella infections, recording 226 cases this year and 150 in June alone, with six deaths reported. Out...
23 Jun, 2026, 12.06 PM IST
Surge in viral infections pushes up pharma salesThe volumes were tepid in January, but with flu, Covid-19 and other viral infections spreading fast, February and March saw spikes in volum...
10 Apr, 2023, 12.43 AM IST
In a first, IISER scientists sequence genome of Giloy plantAccording to the team, the genome and transcriptome sequencing of Giloy (Tinospora cordifolia) is important due to its tremendous use in ph...
06 Sep, 2021, 02.55 PM IST
Panic buying of drugs down since mid-AprilSales of anti-infective medicines in the April 1-22 period eased to 62% from levels seen from March 1to 22. While sales of antidiabetes dru...
28 Apr, 2020, 08.12 AM IST
Drug sales reveal our lifestyle woesIndians spent over Rs 1,36,000 cr on medicines in last one year ending September 2019. People spent over Rs 17,000 cr on cardiac drugs, aro...
22 Oct, 2019, 11.01 AM IST
Government undertaking research to promote use of cow urine, Lok Sabha toldA pharmaceutical product containing cow urine distillate with anti-oxidant property is available in the market and that four US patents hav...
25 Nov, 2016, 07.36 PM IST
Gastrointestinal drug sales show highest incremental gain in a yearAnti-infective cough and cold medication still tops the chart, with sales totalling Rs 14,735 crore in the domestic organised retail market.
05 Feb, 2016, 12.48 PM IST
Anti-diabetic drug tops India's pharma salesIn a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation ...
18 Jun, 2014, 01.27 PM IST
- Merck, Ranbaxy drug development deal called off
US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, whi...
06 Jan, 2011, 02.44 PM IST